# HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China

> **NCT06238284** · — · UNKNOWN · sponsor: **Chongqing University Cancer Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Cervical Cancer
- Endometrial Cancer
- Ovarian Cancer
- HER2 Expression

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT06238284
- **Lead sponsor:** Chongqing University Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-26
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06238284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06238284, "HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06238284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*